Cereno Scientific publishes interim report for Q3 2022
The Board and Chief Executive Officer of Cereno Scientific AB here presents the interim report for Q3, 1 July – 30 September, 2022.Summary of the third quarter, July – September 2022 Cereno Scientific Group Third quarter (1 July – 30 September) · Net Sales were SEK 0 (0) · Result after financial items was SEK -7,248,364 (-3,356,309) · Earnings per share was SEK -0.07 (-0.05) before dilution and SEK -0.05 (-0.02) after dilution · The equity/assets ratio was 93.2% (89.9%) · Cash and bank balance was SEK 36,569,272 (28,583,402) Parent company Third quarter (1